Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/16/2017 02/17/2017 02/21/2017 02/22/2017 02/23/2017 Date
52.78(c) 52.51(c) 53.47(c) 53.38(c) 53.58(c) Last
12 881 819 8 167 474 5 931 413 3 596 975 4 673 432 Volume
-4.30% -0.51% +1.83% -0.17% +0.37% Change
More quotes
Financials ($)
Sales 2017 5 165 M
EBIT 2017 1 789 M
Net income 2017 1 076 M
Debt 2017 1 995 M
Yield 2017 0,78%
Sales 2018 5 493 M
EBIT 2018 1 992 M
Net income 2018 1 285 M
Debt 2018 1 680 M
Yield 2018 0,88%
P/E ratio 2017 24,82
P/E ratio 2018 20,70
EV / Sales2017 5,49x
EV / Sales2018 5,10x
Capitalization 26 359 M
More Financials
Company
Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.The company was founded in July 2012 and is headquartered in New York, NY. 
Sector
Pharmaceuticals
Calendar
05/09Earnings Release
More about the company
Surperformance© ratings of Zoetis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ZOETIS INC
09:04a ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
02/17 ZOETIS : Statement on the Positive Opinion for Cytopoint Adopted by the European..
02/17 ZOETIS : to Participate in the Cowen and Company 37th Annual Health Care Confere..
02/16 ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
02/16DJZOETIS : Dims Outlook
02/16 ZOETIS : tops 4Q profit forecasts
02/16 ZOETIS INC. : Results of Operations and Financial Condition, Financial Statement..
02/16 ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
02/15 ZOETIS : Receives European Commission Approval for Stronghold® Plus
02/15 ZOETIS INC. (NYSE : ZTS) Files An 8-K Regulation FD Disclosure
More news
Sector news : Veterinary Drugs
12:59a Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
02/23DJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
More sector news : Veterinary Drugs
Latest Tweets
02/23Phibro Animal Health: Good Company, Good Performance, Questionable Price  
02/22Fox News bureau - Denver. Photo credit: @david_glenn_smith
43
02/20Zoetis Inc $ZTS Forecasted to Post FY2021 Earnings of $3.90 Per Share  
02/20Zoetis Inc $ZTS Releases FY17 Earnings Guidance  
02/19Zoetis's outperform rating reiterated at BMO Capital Markets. $60.00 PT.  
More tweets
Qtime:64
News from SeekingAlpha
02/23 PHIBRO ANIMAL HEALTH : Good Company, Good Performance, Questionable Price
02/17 Tracking George Soros's Portfolio - Q4 2016 Update
02/16 Zoetis (ZTS) Q4 2016 Results - Earnings Call Transcript
02/16 Zoetis earnings up 142%; non-GAAP EPS up 11% in FY16; updates 2017 guidance
02/16 Tracking Bill Ackman's Pershing Square Portfolio - Q4 2016 Update
Advertisement
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Full-screen chart
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 58,7 $
Spread / Average Target 9,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC-0.28%26 359
JINYU BIO-TECHNOLOGY C..49.34%3 066
DECHRA PHARMACEUTICALS..15.32%1 798
SHANGHAI HILE BIO TECH..-4.71%1 590
VIRBAC2.12%1 549
PULIKE BIOLOGICAL ENGI..5.58%1 205
More Results